Treatment patterns, visual acuity and quality-of-life outcomes of the WAVE study - A noninterventional study of ranibizumab treatment for neovascular age-related macular degeneration in Germany

Delay to Treatment and Visual Outcomes in Patients Treated With Anti-Vascular Endothelial Growth Factor for Age-Related Macular Degeneration

(2012) Jonathan H. Lim et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Safety and Efficacy of a Flexible Dosing Regimen of Ranibizumab in Neovascular Age-Related Macular Degeneration: The SUSTAIN Study

(2011) Frank G. Holz et al.   OPHTHALMOLOGY

Interobserver variability for retreatment indications after Ranibizumab loading doses in neovascular age-related macular degeneration

(2010) Carsten Framme et al.   ACTA OPHTHALMOLOGICA

Incidence of rhegmatogenous retinal detachments after intravitreal antivascular endothelial factor injections

(2010) Carsten H. Meyer et al.   ACTA OPHTHALMOLOGICA

Risks of Mortality, Myocardial Infarction, Bleeding, and Stroke Associated With Therapies for Age-Related Macular Degeneration

(2010) Lesley H. Curtis   ARCHIVES OF OPHTHALMOLOGY

Effectiveness of ranibizumab for neovascular age-related macular degeneration using clinician-determined retreatment strategy

(2010) A. Kumar et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Effectiveness of intravitreal ranibizumab for the treatment of neovascular age-related macular degeneration in a Canadian retina practice: a retrospective review

(2010) Taha Bandukwala et al.   CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE

The As-Needed Treatment Strategy for Choroidal Neovascularization: A Feedback-Based Treatment System

(2009) Richard F. Spaide   AMERICAN JOURNAL OF OPHTHALMOLOGY

Time between Symptom Onset and Assessment in Age-Related Macular Degeneration with Subfoveal Choroidal Neovascularization

(2009) Rainer Schalnus et al.   OPHTHALMOLOGICA

A Phase IIIb Study to Evaluate the Safety of Ranibizumab in Subjects with Neovascular Age-related Macular Degeneration

(2009) David S. Boyer et al.   OPHTHALMOLOGY

Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1

(2008) Carl D. Regillo et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Monitoring von AMD-Patienten unter Anti-VEGF-Therapie

(2008) C.H. Meyer et al.   OPHTHALMOLOGE